Growing at an Unbelievable Rate: Contineum Therapeutics Inc. (CTNM) Stock
Stifel raised the price target for the Contineum Therapeutics Inc. (NASDAQ:CTNM) stock to “a Buy”. The rating was released on April 30, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $25. The latest trade, Performances and Moving Averages give us the […]
The latest Contineum Therapeutics Inc. (CTNM) Stock Technical Bulletin
Stifel raised the price target for the Contineum Therapeutics Inc. (NASDAQ:CTNM) stock to “a Buy”. The rating was released on April 30, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $25. The latest trade, Performances and Moving Averages give us the […]
Contineum Therapeutics Inc. (NASDAQ:CTNM) stock Market Value Reached at $489.97 million: What Happened?
Stifel raised the price target for the Contineum Therapeutics Inc. (NASDAQ:CTNM) stock to “a Buy”. The rating was released on April 30, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $25. The latest trade, Performances and Moving Averages give us the […]
Analyzing Contineum Therapeutics Inc.’s (CTNM) Stock earnings per share and revenue
Stifel raised the price target for the Contineum Therapeutics Inc. (NASDAQ:CTNM) stock to “a Buy”. The rating was released on April 30, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $25. The latest trade, Performances and Moving Averages give us the […]
